ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VRAX Virax Biolabs Group Ltd

0.69001
-0.00999 (-1.43%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Virax Biolabs Group Ltd VRAX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.00999 -1.43% 0.69001 08:00:01
Open Price Low Price High Price Close Price Previous Close
0.681 0.665 0.7331 0.69001 0.70
more quote information »

Recent News

Date Time Source Heading
25/4/202422:00PRNUSVirax Biolabs Launches Portfolio of Immune Profiling..
16/4/202421:30PRNUSVirax Biolabs to Participate at ESCMID Global 2024
16/3/202407:30PRNUSVirax Biolabs Announces Receipt of NASDAQ Notification..
23/1/202409:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202409:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202423:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202323:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202323:30PRNUSVirax Biolabs Forges Strategic Research Collaboration with..
21/12/202308:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/12/202308:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202308:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/12/202323:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/202323:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
18/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
14/12/202323:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202323:30PRNUSVirax Biolabs Group Limited Announces 1-for-10 Share..
08/12/202322:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202308:06EDGAR2Form F-3 - Registration statement by foreign private issuers
09/11/202308:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202307:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202322:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202321:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202321:30PRNUSVirax Biolabs Group Announces Early-Access Program Launch of..
01/9/202321:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202321:30PRNUSVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief..
03/8/202322:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202321:30PRNUSNasdaq Approves 180-Day Extension for Virax Biolabs Group to..
18/7/202321:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202321:30PRNUSVirax Biolabs Group Continues Growth and Expansion with the..
14/6/202321:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
04/5/202321:30PRNUSVirax Biolabs Group Announces Establishment of Regional..

Your Recent History

Delayed Upgrade Clock